A multicenter, randomized, open label study to compare the safety and efficacy of levofloxacin with that of imipenem/cilastatin in the treatment of nosocomial pneumonia.

Trial Profile

A multicenter, randomized, open label study to compare the safety and efficacy of levofloxacin with that of imipenem/cilastatin in the treatment of nosocomial pneumonia.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 May 2009

At a glance

  • Drugs Imipenem/cilastatin; Levofloxacin
  • Indications Bacterial infections; Nosocomial pneumonia
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 May 2009 Planned number of patients changed from 400 to 438 as reported by ClinicalTrials.gov.
    • 20 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top